[AQST] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[AQST] Aquestive Therapeutics, Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 58.79%
YoY- -277.94%
Quarter Report
AQST's Result
AQST's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 13,002 11,463 13,287 8,260 12,418 13,267 27,146 -11.54%
PBT -2,175 -12,536 -14,555 -16,551 -18,412 -15,038 8,451 -
Tax -140 5 -1 8 2,652 1,932 0 -
NP -2,035 -12,536 -14,555 -16,551 -18,412 -15,038 8,451 -
Tax Rate - - - - - - 0.00% -
Total Cost 15,037 23,999 27,842 24,811 30,830 28,305 18,695 -3.56%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -15.65 -109.36 -109.54 -200.38 -148.27 -113.35 31.13 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.03 -0.23 -0.37 -0.49 -0.74 -0.64 0.39 -
EPS Diluted -0.03 -0.23 -0.37 -0.49 -0.74 -0.64 0.39 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.